GlassScriptPhysician profile
Olivia Goitia
NPI 1821737826
$757.27
in general payments reported to CMS, 2019-2025
16 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $160 · 2024: $210 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $114.98 | 2024-2025 | Bexsero, Trelegy Ellipta |
| Vanda Pharmaceuticals INC. | $104.68 | 2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $96.82 | 2023-2025 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $72.06 | 2023-2024 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $62.18 | 2025 | |
| Exact Sciences Corporation | $59.95 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Neurocrine Biosciences, INC. | $46.99 | 2023 | Ingrezza |
| Merck Sharp & Dohme LLC | $34.11 | 2024-2025 | Proquad, Gardasil 9, Capvaxive |
| Cranial Technologies, INC | $27.94 | 2023 | Doc Band |
| Gilead Sciences, INC. | $25.62 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.81 | 2025 | Jardiance |
| Alkermes, INC. | $22.63 | 2025 | Aristada, Lybalvi |
| Bayer Healthcare Pharmaceuticals INC. | $17.61 | 2024 | |
| Axsome Therapeutics, INC. | $17.46 | 2023 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.00 | 2024 | Caplyta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.43 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Goitia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.